U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT06916000) titled 'Assessment of PENG Block as a Part of Multimodal Analgesia Following Hip Surgeries.' on Nov. 28, 2024.
Brief Summary: to study the effect of Pericapsular nerve group (PENG) block as a part of multimodal analgesia regimen for hip arthroplasties
Study Start Date: June 27, 2024
Study Type: INTERVENTIONAL
Condition:
Anesthesia
Intervention:
DRUG: Pericapsular nerve group (PENG) block
As a part of multimodal analgesia patients will receive 20 ml of 0.25% bupivcacaine according to the technique described by Giron-Arango.
All patients will receive the same analgesic protocol, which included IV paracetamol 1000 mg BID and NSAIDs if ...